Jumio Adds AAMVA Driver’s License Data Verification Service to its Growing Suite of Data-Driven Solutions
Leading identity verification service adds additional fraud signals that verify information on driver’s licenses, provide…
6 years ago
EpimAb Biotherapeutics Presents Preclinical Data Characterizing EMB-01 at AACR Virtual Annual Meeting II
EMB-01 is found to induce co-degradation of EGFR and cMet in various tumor cells SHANGHAI--(BUSINESS…
6 years ago
Nanox Enters Asia Pacific: Signs Strategic Agreement With Golden Vine International for the Deployment of 500 Nanox.ARC Systems in Taiwan and Singapore
Radical plan aims Taiwan to become a country-wide center of excellence for 21st century early-detection…
6 years ago
Amid Turmoil, 2020 Tang Prize Laureates Strive for An Orderly New World
TAIPEI, TAIWAN - Media OutReach - 22 June 2020 - The theme of the 2020 Tang Prize, "for…
6 years ago
Celanese Extends and Enhances Key Carbon Monoxide Feedstock Contract for Nanjing, China Site
DALLAS & SHANGHAI--(BUSINESS WIRE)--$CE #Celanese--Celanese Corporation (NYSE: CE), a global chemical and specialty materials company,…
6 years ago
Vancity and Women’s Enterprise Centre launch Unity Women Entrepreneurs Program to support women entrepreneurs impacted by COVID-19
The program offers financing of up to $150K interest-free for six months, business support and…
6 years ago
Merck’s KEYTRUDA® (pembrolizumab) Approved in China for Second-Line Treatment of Patients with Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma Whose Tumors Express PD-L1 (CPS ?10)
KEYTRUDA Is Now Approved Across Five indications for Three Different Types of Cancer in China…
6 years ago
3Q20 Server Orders to Face Adjustments in Light of Relatively High Server Barebones Inventory, Says TrendForce
TAIPEI, Taiwan--(BUSINESS WIRE)--#COVID19--According to the latest investigations by the DRAMeXchange research division of TrendForce, the…
6 years ago
Toshiba Nominates Highly-Qualified Slate of Directors, Issues Public Shareholder Letter
Company Nominates Osamu Nagayama as New Chairperson of the Board Eleven Directors on Company Slate…
6 years ago
Mainstay Medical Announces U.S. FDA Approval of ReActiv8® Neurostimulation System for Chronic Low Back Pain
U.S. commercialization expected to begin in the first half of 2021 Continues positive momentum for…
6 years ago